Latest Publications

Share:

Therasense Revisited: In re Rosuvastatin Calcium Patent Litigation

In the United States, patent applicants and their counsel owe a duty of candor and good faith to the Patent Office. This duty is breached when the applicant or its counsel knowingly fails to disclose material prior art...more

4/18/2013 - America Invents Act Deceptive Intent Disclosure Requirements Failure to Report Good Faith Inequitable Conduct Patent Litigation Patent Reform Patents Prior Art Rosuvastatin USPTO

1 Results
|
View per page
Page: of 1